Polymeric nanoparticles for the drug delivery to the central nervous system.
about
Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live trackingDevelopment of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidencesTargeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage DisordersMR-based molecular imaging of the brain: the next frontier.Nanomedicine--challenge and perspectives.Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles.Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles.Novel treatment strategies for brain tumors and metastases.Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging.Comparison of protein- and polysaccharide-based nanoparticles for cancer therapy: synthesis, characterization, drug release, and interaction with a breast cancer cell line.Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes.Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits.Various drug delivery approaches to the central nervous system.Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to β-endorphin?Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.Drug delivery to the CNS and polymeric nanoparticulate carriers.Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors.Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.Nanobiotechnology-based strategies for crossing the blood-brain barrier.Novel siRNA delivery strategy: a new "strand" in CNS translational medicine?Nanotechnology Approaches for the Delivery of Exogenous siRNA for HIV Therapy.Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model.Nano carriers for drug transport across the blood-brain barrier.Advanced interstitial chemotherapy for treating malignant glioma.Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes.Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia.Methotrexate-loaded chitosan- and glycol chitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors.Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents.In vivo real-time fluorescence visualization and brain-targeting mechanisms of lipid nanocarriers with different fatty ester:oil ratios.Nanomaterials in controlled drug release.Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice.Effect of Neonatal Exposure to Poly(Ethylene Glycol)-block-Poly(Lactic Acid) Nanoparticles on Oxidative State in Infantile and Adult Female RatsPreparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.MicroRNA in Glioblastoma: An Overview.Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression.Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?Brain targeting with polymeric nanoparticles: which administration route should we take?
P2860
Q28067855-3DFB1046-6707-4731-9D7A-7934E36BCC76Q28477471-16CC4C6C-CA22-4E54-A970-0B5610D63F60Q28552459-DBE1374E-7389-42D6-8947-3EF8AFC53231Q33701395-682A29A6-913E-42E7-B835-6069E860F486Q34247073-2ACEDA04-0DCF-4380-9772-9C438FD9C0C2Q34701454-E4FE8791-5E8E-448F-913E-5101BBFCF2BFQ35671789-3F60F911-AA87-44E2-8874-DC7EDA2F2839Q35734471-8EDA0BF0-D0CB-45AD-A858-C708056C5167Q35972521-E8092B2B-923D-4412-AAF0-67C6EEC05901Q35992063-AF7B92E2-6FD3-484F-BD71-F8376EA56E4CQ37137363-C9CAF413-A0F3-4BA1-A55E-46B3C28E6FD4Q37354471-B3F82993-C5BE-4F11-BB77-71A69929F056Q37657525-37C59F34-AE19-4E40-9587-A492FA5531F7Q37697436-CA234F4D-0CFA-4B11-8EB6-57DBEFFB7F3DQ37702246-076417FC-88B1-430F-8EFD-D9812123EDFFQ37856301-DA56046D-DBCF-4938-BBF6-9F0EF9AD077FQ37967666-88014F48-8ECC-4D74-80CB-B48632E624A1Q37995554-5FB180D9-B6AE-4920-B323-D31B85A28641Q38038895-8938B27A-F37B-41F6-9A5D-35B918C665F4Q38091009-EEC42DAA-0A30-40DE-8565-A7C8AB4ED17EQ38622404-9586A64A-67D7-4358-B821-875249CB3F3DQ38647131-80ED1335-1918-4881-9C6A-C458C7D2A285Q38820474-E4640951-4E8A-428C-8EC2-2C5DBD9E0091Q38849948-7E1B4E9C-638C-44F0-A71F-916B5D2B2D3BQ38938545-E285A3CF-4EE4-4CC5-99D8-E61F7480CCE6Q39154878-13C0FA1B-3C4C-4EED-A3FA-09A7D89D8163Q39214441-1B2B15D3-C040-4453-8B33-CD34DA51BB41Q39424092-EF4BB027-EBE9-4639-B4C8-D4E096E1DB12Q39438422-6031C7F0-6695-4DC3-8ACA-189F48ADAADDQ39444327-FA5625ED-DEBD-497F-BCB2-64268B0B0431Q39733465-01E3195E-EB51-41E2-80D8-CF1263BB504AQ40295370-0BF306C3-42EB-4BC3-A290-44F8028CD356Q42730492-C3AB31E3-C6D7-4006-9AFC-BA4DFBD9F724Q43083731-5AC2C252-F5B9-42CA-B5AF-21ED154ABD0DQ47142132-193FEB44-007F-4B0E-819C-57E6E19166C7Q47743028-180E43E3-6E52-470C-BC16-1B0A12BBDD86Q48081345-A64885D7-AAE6-4898-9B19-93BDE3D9858DQ48627318-F411B8AF-88CA-4157-88C3-CF351A06D172Q48872882-5EFB4F63-11EF-46E0-B372-D5DA2018B8FDQ49102381-6CF2B017-8399-4284-B677-7694E80468CF
P2860
Polymeric nanoparticles for the drug delivery to the central nervous system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polymeric nanoparticles for the drug delivery to the central nervous system.
@en
Polymeric nanoparticles for the drug delivery to the central nervous system.
@nl
type
label
Polymeric nanoparticles for the drug delivery to the central nervous system.
@en
Polymeric nanoparticles for the drug delivery to the central nervous system.
@nl
prefLabel
Polymeric nanoparticles for the drug delivery to the central nervous system.
@en
Polymeric nanoparticles for the drug delivery to the central nervous system.
@nl
P2860
P50
P356
P1476
Polymeric nanoparticles for the drug delivery to the central nervous system.
@en
P2860
P304
P356
10.1517/17425247.5.2.155
P407
P577
2008-02-01T00:00:00Z